Adcock Ingram Holdings Ltd | AIP

Adcock Ingram Holdings Ltd traded at 5,153.00 this Tuesday May 17th, decreasing 47.00 or 0.90 percent since the previous trading session. Looking back, over the last four weeks, Adcock Ingram Holdings Ltd lost 5.12 percent. Over the last 12 months, its price rose by 16.58 percent. Looking ahead, we forecast Adcock Ingram Holdings Ltd to be priced at 5,084.37 by the end of this quarter and at 4,644.68 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
5,153.00
Daily Change
-0.90%
Yearly
16.58%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Aspen Pharmacare 15,786.00 144.00 0.92% -4.40%
Life Healthcare 1,927.00 20.00 1.05% -5.17%
Netcare 1,523.00 9.00 0.59% 2.21%


Adcock Ingram Holdings Ltd
Adcock Ingram Holdings Limited is a healthcare company. The Company is a pharmaceutical manufacturer, which manufactures, markets and distributes a range of healthcare products, and supplies to both the private and public sectors of the market. The Company's segments include Over the Counter (OTC), Consumer, Prescription and Hospital. The OTC segment focuses primarily on brands sold predominantly in the pharmacy market. The Consumer segment is engaged in the fast moving consumer goods (FMCG) space. The Prescription segment markets products prescribed by medical practitioners. The Hospital segment operates as a supplier of hospital and critical care products, including intravenous solutions, blood collection products and renal dialysis systems. The Company's products include Allergex Non-Drowsy, Panado Paed Syrups, Probiflora Infant, Cepacol, Medi-Keel A, Adco-Acyclovir Topical Cream and Adco-Normospor Vaginal Cream.